Dr. Christopher David Centafont, DO

Dr. Centafont practices at Southeast Cardiology Clinic Inc. in Dothan, Alabama.

Dr. Centafont's NPI, 1447239595, was assigned on January 16, 2006. Dr. Centafont graduated from University of Texas Medical Branch at Galveston in 1994. Dr. Centafont holds Alabama license 378-DO.

Dr. Centafont's primary practice is Southeast Cardiology Clinic Inc., at 1150 Ross Clark Cir, Dothan, AL 36301 in Houston County. The practice phone is (334) 712-1929.

Dr. Centafont's primary practice is Southeast Cardiology Clinic Inc. in Dothan, Alabama. Dr. Centafont is also affiliated with Southeast Health Medical Center. The medical group on file is Southeast Health Enterprise Clinic. Dmand AI also links Dr. Centafont to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Centafont practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Centafont's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Centafont is licensed in Alabama.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Centafont treats.

CMS data shows 10,302 Medicare services from Dr. Centafont across 26 procedure codes in 2024, for 1,428 Medicare patients. Medicare paid $613,962 for them.

CMS counts 1,428 Medicare patients who saw Dr. Centafont in 2024. The largest group is 75 to 84, with 567 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Centafont's median patient age at 71, with 51% women.

In 2024, Dr. Centafont wrote 13,831 Medicare Part D claims for 1,764 patients. 86% of them were for generic drugs. CMS names the drug for 13,534 of them, across 67 drugs with 11 or more claims each, at $1,921,045 in total drug cost. In 2023, CMS named 12,086 claims across 67 drugs.

Dr. Centafont accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 420 general payments to Dr. Centafont from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,021.

Dmand AI lists 1 award for Dr. Centafont.

Dr. Centafont graduated from University of Texas Medical Branch at Galveston in 1994.

Dr. Centafont is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.